X. Yan

Metabolite changes during the life history of Porphyra haitanensis.

J. Chen, Q. Luo, H. Chen, 2015, Plant biology.

Toripalimab (anti-PD-1) versus High-Dose Interferon-α2b as Adjuvant Therapy in Resected Mucosal Melanoma: A Phase II Randomized Trial.

K. Li, X. Bai, C. Cui, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma.

S. Li, X. Bai, C. Cui, 2017, Neoplasma.

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

C. Balch, Li Zhou, S. Li, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.

Y. Wang, A. Schneeweiss, Ming Yan, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

229P Dalpiciclib plus fulvestrant in HR+/HER2− advanced breast cancer (ABC): Updated analysis from the phase III DAWNA-1 trial

X. Wu, W. Li, Z. Tong, 2022, Annals of Oncology.